| Literature DB >> 32280521 |
Yiyi Feng1,2, Chuandi Zhou1,2, Renbing Jia1,2, Yefei Wang1,2, Xianqun Fan1,2.
Abstract
PURPOSE: To assess the quality of life (QoL) and the long-term psychosocial outcomes in adult survivors of unilateral retinoblastoma (RB).Entities:
Year: 2020 PMID: 32280521 PMCID: PMC7125462 DOI: 10.1155/2020/4384251
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
Characteristics of RB survivors and the control group.
| Variable | All RB survivors ( | Survivors with radiotherapy ( | Survivors without radiotherapy ( | Control group ( |
|
|
|---|---|---|---|---|---|---|
|
| 0.400 | 0.056 | ||||
| Mean (SD), years | 27.94 (7.63) | 26.24 (6.16) | 30.72 (9.03) | 29.18 (8.37) | ||
| Median (IQR), years | 25.50 (22.00–32.25) | 25.00 (21.50–30.50) | 29.00 (23.00–38.50) | 26.00 (22.00–34.00) | ||
|
| NA | 0.042 | ||||
| Mean (SD), years | 3.15 (4.43) | 2.85 (1.48) | 3.64 (7.01) | NA | ||
| Median (IQR), years | 2.00 (1.00–4.00) | 3.00 (2.00–4.00) | 1.00 (1.00–3.00) | NA | ||
|
| 0.110 | 0.376 | ||||
| Female | 35 (57.0%) | 20 (48.8%) | 15 (60.0%) | 44 (66.7%) | ||
| Male | 31 (43.0%) | 21 (51.2%) | 10 (40.0%) | 22 (33.3%) | ||
|
| 0.829 | 0.573 | ||||
| Completed junior high school or less | 8 (12.1%) | 6 (14.6%) | 2 (8.0%) | 14 (21.2%) | ||
| Completed high school | 20 (30.3%) | 12 (29.3%) | 8 (32.0%) | 13 (19.7%) | ||
| Completed university or more | 37 (56.1%) | 22 (53.7%) | 15 (60.0%) | 39 (59.1%) | ||
| Unknown/missing | 1 (1.5%) | 1 (2.4%) | 0 | 0 | ||
|
| 0.295 | 0.474 | ||||
| Single | 38 (57.6%) | 25 (61.0%) | 13 (52.0%) | 32 (48.5%) | ||
| Married | 28 (42.4%) | 16 (39.0%) | 12 (48.0%) | 34 (51.5%) | ||
|
| 0.415 | 0.874 | ||||
| Light | 32 (48.5%) | 20 (48.8%) | 12 (48.0%) | 24 (36.4%) | ||
| Medium | 22 (33.3%) | 14 (34.1%) | 8 (32.0%) | 33 (50.0%) | ||
| Heavy | 12 (18.2%) | 7 (17.1%) | 5 (20.0%) | 9 (13.6%) | ||
|
| 0.691 | 0.641 | ||||
| Yes | 48 (72.7%) | 12 (29.3%) | 6 (24.0%) | 50 (75.8%) | ||
| No | 18 (27.3%) | 29 (70.7%) | 19 (76.0%) | 16 (24.2%) | ||
|
| 0.419 | |||||
| Yes | 52 (78.8%) | 31 (75.6%) | 21 (84.0%) | NA | NA | |
| No | 14 (21.2%) | 10 (24.4%) | 4 (16.0%) | NA | NA | |
|
| 0.308 | |||||
| Yes | 11 (16.7%) | 5 (12.2%) | 6 (24.0%) | NA | NA | |
| No | 55 (83.3%) | 36 (87.8%) | 19 (76.0%) | NA | NA |
SD, standard deviation; IQR, interquartile range; NA, not applicable; RB, retinoblastoma. pa, p value compared characteristic differences between RB survivors with or without radiotherapy. p, p value compared characteristic differences between RB survivors and the control group.
RB survivors versus the control group and RB survivors with radiotherapy versus RB survivors without radiotherapy in the SF-36.
| Domain median (IQR) | All RB survivors ( | Survivors with radiotherapy ( | Survivors without radiotherapy ( | Control group ( |
|
|
|
|---|---|---|---|---|---|---|---|
| Physical functioning | 100.00 (95.00–100.00) | 100.00 (100.00–100.00) | 100.00 (95.00–100.00) | 95.00 (90.00–100.00) | 0.001 | 0.081 | 0.170 |
| Role-physical | 87.50 (50.00–100.00) | 100.00 (75.00–100.00) | 75.00 (37.50–100.00) | 100.00 (50.00–100.00) | 0.089 | 0.200 | 0.321 |
| Bodily pain | 100.00 (72.00–100.00) | 100.00 (72.00–100.00) | 100.00 (72.00–100.00) | 74.00 (69.50–100.00) | 0.011 | 0.572 | 0.703 |
| General health | 75.00 (55.00–87.00) | 77.00 (57.00–87.00) | 62.00 (52.00–82.00) | 71.00 (52.00–85.50) | 0.529 | 0.129 | 0.105 |
| Vitality | 75.00 (65.00–80.00) | 80.00 (70.00–85.00) | 75.00 (60.00–80.00) | 70.00 (55.00–80.00) | 0.076 | 0.115 | 0.152 |
| Social functioning | 90.00 (76.88–100.00) | 90.00 (71.25–100.00) | 87.50 (77.50–100.00) | 87.50 (77.50–100.00) | 0.531 | 0.629 | 0.891 |
| Role-emotional | 100.00 (66.67–100.00) | 100.00 (66.67–100.00) | 100.00 (33.33–100.00) | 66.67 (0.00–100.00) | 0.002 | 0.268 | 0.350 |
| Mental health | 80.00 (64.00–84.00) | 80.00 (72.00–84.00) | 80.00 (62.00–84.00) | 72.00 (60.00–84.00) | 0.119 | 0.436 | 0.278 |
p a, p values were analysed after adjusting for age at diagnosis.
RB survivors versus the control group and RB survivors with radiotherapy versus RB survivors without radiotherapy in the HAD.
| All RB survivors ( | With radiotherapy ( | Without radiotherapy ( | Control group ( |
|
|
| |
|---|---|---|---|---|---|---|---|
| Anxiety, median (IQR) | 4.00 (2.00–6.00) | 4.00 (1.00–6.00) | 4.00 (2.50–6.00) | 5.00 (2.75–8.25) | 0.045 | 0.406 | 0.534 |
| Positive, | 9 (14.1%) | 5 (12.8%) | 4 (16.0%) | 18 (27.3%) | 0.063 | 0.728 | 0.993 |
| Depression, median (IQR) | 2.00 (1.00–5.00) | 2.00 (1.00–5.00) | 2.00 (1.00–6.00) | 4.00 (1.75–7.00) | 0.080 | 0.713 | 0.957 |
| Positive, | 6 (9.4%) | 4 (10.3%) | 2 (8.0%) | 12 (18.2%) | 0.146 | 1.000 | 0.521 |
Two patients were excluded because of missing data. pa, p values were analysed after adjusting for age at diagnosis.
RB survivors versus the control group and male versus female in the NPSS-F
| All RB survivors ( | Male ( | Female ( | Control group ( |
|
| |
|---|---|---|---|---|---|---|
| Total score, median (IQR)/mean (SD) | 1.59 (1.27–2.16) | 1.46 (0.77) | 1.88 (0.84) | 0.36 (0.09–1.18) | <0.001 | 0.041 |
| Unsatisfied, | 20 (31.3%) | 8 (26.7%) | 12 (35.3%) | 3 (4.5%) | <0.001 | 0.461 |
| Cognition-affect (CA), median (IQR) | 1.63 (0.50–2.25) | 1.38 (0.50–2.00) | 2.00 (1.00–2.56) | 0.50 (0.00–1.00) | <0.001 | 0.039 |
| Behavior (B), median (IQR) | 3.00 (2.00–3.33) | 2.50 (1.00–3.50) | 3.00 (2.00–3.33) | 0.67 (0.00–1.67) | <0.001 | 0.475 |
| Projection (P), median (IQR) | 1.00 (0.25–1.75) | 1.00 (0.00–1.50) | 1.13 (0.44–2.00) | 0.25 (0.00–1.00) | <0.001 | 0.282 |
Two patients were excluded because of missing data. p, p value compared NPSS-F scores between males and females.
Male versus female in the FoP-Q-SF.
| All RB survivors ( | Male ( | Female ( |
| |
|---|---|---|---|---|
| Total score, mean (SD) | 27.14 (8.39) | 24.37 (6.92) | 29.59 (8.89) | 0.031 |
| Total score, median (IQR) | 27.00 (21.25–32.00) | 26.00 (17.50–29.25) | 28.50 (23.75–35.00) | |
| >34, | 9 (14.1%) | 1 (3.3%) | 8 (23.5%) | 0.021 |
p, p value compared FoP-Q-SF scores between males and females.
Univariate analysis and multivariate regression analysis of factors affecting FoP-Q-SF scores and NPSS-F scores.
| Variable | FoP-Q-SF | NPSS-F | ||||||
|---|---|---|---|---|---|---|---|---|
| Univariate analysis | Multivariable analysis | Univariate analysis | Multivariable analysis | |||||
|
|
|
|
|
|
|
|
| |
| Age at study | −0.02 (−0.32 to 0.27) | 0.866 | NA | NA | −0.01 (−0.04 to 0.02) | 0.631 | NA | NA |
| Age at diagnosis | 0.18 (−0.29 to 0.65) | 0.450 | NA | NA | −0.01 (−0.05 to 0.04) | 0.845 | NA | NA |
| Education | 0.25 (−2.74 to 3.25) | 0.866 | NA | NA | −0.14 (−0.44 to 0.15) | 0.335 | NA | NA |
| Financial burden | 2.30 (−0.39 to 4.99) | 0.092 | 1.96 (−0.64 to 4.56) | 0.137 | 0.21 (−0.06 to 0.48) | 0.122 | NA | NA |
| Sex | 5.22 (1.20 to 9.24) | 0.012 | 4.90 (0.90 to 8.90) | 0.017 | 0.42 (0.02 to 0.83) | 0.041 | 0.41 (0.01 to 0.80) | 0.045 |
| Marital status | −1.60 (−5.88 to 2.68) | 0.459 | NA | NA | −0.22 (−0.65 to 0.20) | 0.293 | NA | NA |
| Living with family or friend | 1.97 (−2.70 to 6.64) | 0.402 | NA | NA | 0.27 (−0.19 to 0.73) | 0.238 | NA | NA |
| Orbital implant | −0.18 (−5.29 to 4.93) | 0.944 | NA | NA | 0.47 (−0.03 to 0.96) | 0.063 | 0.45 (−0.04 to 0.93) | 0.069 |
| Chemotherapy | −1.37 (−6.96 to 4.22) | 0.627 | NA | NA | 0.12 (−0.44 to 0.67) | 0.680 | NA | NA |
| Radiotherapy | 0.75 (−3.57 to 5.08) | 0.729 | NA | NA | −0.27 (−0.69 to 0.16) | 0.214 | NA | NA |
A linear regression model was used to examine the association between scale scores and the independent variables. β, the regression coefficient; CI, confidence interval. Variables with p > 0.10 in univariate analysis were not included in the multivariate model and are indicated by NA in the table.